loading...| Preferred Name |
Levomepromazine |
|
| Synonyms |
Methotrimeprazine (-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine Levomepromazine LEVOMEPROMAZINE Arc-VI-C-5 Bayer 1213 Levoprome Neozine Nirvan Nozinan |
|
| Definitions |
A phenothiazine and typical antipsychotic agent, with sedative/hypnotic, anxiolytic, antiemetic, analgesic and antipsychotic activities. Although the exact mechanism of action of levomepromazine is not fully known, upon administration, this agent appears to act as an antagonist for a variety of receptors in the central nervous system (CNS), including adrenergic, dopamine, histamine, cholinergic and serotonin (5-hydroxytryptamine; 5-HT) receptors. Blocking these receptors results in levomepromazine's pharmacologic effects. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C66118 |
|
| CAS_Registry |
60-99-1 |
|
| CHEBI_ID |
CHEBI:6838 |
|
| Chemical_Formula |
C19H24N2OS |
|
| code |
C66118 |
|
| Concept_In_Subset | ||
| Contributing_Source |
FDA |
|
| DEFINITION |
A phenothiazine and typical antipsychotic agent, with sedative/hypnotic, anxiolytic, antiemetic, analgesic and antipsychotic activities. Although the exact mechanism of action of levomepromazine is not fully known, upon administration, this agent appears to act as an antagonist for a variety of receptors in the central nervous system (CNS), including adrenergic, dopamine, histamine, cholinergic and serotonin (5-hydroxytryptamine; 5-HT) receptors. Blocking these receptors results in levomepromazine's pharmacologic effects. |
|
| FDA_UNII_Code |
9G0LAW7ATQ |
|
| FULL_SYN |
Methotrimeprazine (-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine Levomepromazine LEVOMEPROMAZINE Arc-VI-C-5 Bayer 1213 Levoprome Neozine Nirvan Nozinan |
|
| Has_Salt_Form | ||
| label |
Levomepromazine |
|
| Legacy Concept Name |
Methotrimeprazine |
|
| Preferred_Name |
Levomepromazine |
|
| prefixIRI |
Thesaurus:C66118 |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0025678 |
|
| subClassOf |